Â鶹´«Ã½

Try our Advanced Search for more refined results

CureVac RNA Vax Patent Survives BioNTech's EU Challenge

By Tabitha Burbidge ( March 28, 2025, 7:57 PM GMT) -- CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention....

Â鶹´«Ã½360 is on it, so you are, too.

A Â鶹´«Ã½360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Â鶹´«Ã½360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Â鶹´«Ã½360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Â鶹´«Ã½ Firms

Companies

Government Agencies